HEADER HYDROLASE 12-DEC-16 5MN5 TITLE S. AUREUS FTSZ 12-316 T66W GTP CLOSED FORM (2TCM) COMPND MOL_ID: 1; COMPND 2 MOLECULE: CELL DIVISION PROTEIN FTSZ; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STAPHYLOCOCCUS AUREUS; SOURCE 3 ORGANISM_TAXID: 1280; SOURCE 4 GENE: FTSZ; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VARIANT: C41 KEYWDS BACTERIAL CELL DIVISION, BACTERIAL CYTOSKELETON, FILAMENTOUS, GTPASE, KEYWDS 2 HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.M.WAGSTAFF,M.TSIM,D.KUREISAITE-CIZIENE,J.LOWE REVDAT 5 17-JAN-24 5MN5 1 REMARK REVDAT 4 24-JAN-18 5MN5 1 SOURCE REVDAT 3 13-SEP-17 5MN5 1 REMARK REVDAT 2 17-MAY-17 5MN5 1 JRNL REVDAT 1 21-DEC-16 5MN5 0 JRNL AUTH J.M.WAGSTAFF,M.TSIM,M.A.OLIVA,A.GARCIA-SANCHEZ, JRNL AUTH 2 D.KUREISAITE-CIZIENE,J.M.ANDREU,J.LOWE JRNL TITL A POLYMERIZATION-ASSOCIATED STRUCTURAL SWITCH IN FTSZ THAT JRNL TITL 2 ENABLES TREADMILLING OF MODEL FILAMENTS. JRNL REF MBIO V. 8 2017 JRNL REFN ESSN 2150-7511 JRNL PMID 28465423 JRNL DOI 10.1128/MBIO.00254-17 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.11.1_2575: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.25 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.850 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.4 REMARK 3 NUMBER OF REFLECTIONS : 12051 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.219 REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.263 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1174 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.2500 - 5.6013 0.96 2668 139 0.1868 0.2019 REMARK 3 2 5.6013 - 4.4473 0.98 2729 144 0.1886 0.2444 REMARK 3 3 4.4473 - 3.8856 0.98 2726 149 0.1952 0.2266 REMARK 3 4 3.8856 - 3.5305 0.98 2716 137 0.2055 0.2823 REMARK 3 5 3.5305 - 3.2775 0.97 2671 184 0.2456 0.2673 REMARK 3 6 3.2775 - 3.0844 0.96 2654 143 0.2720 0.3769 REMARK 3 7 3.0844 - 2.9299 0.96 2675 137 0.2944 0.3298 REMARK 3 8 2.9299 - 2.8024 0.92 2554 141 0.2857 0.3657 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.360 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.770 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 4284 REMARK 3 ANGLE : 0.946 5797 REMARK 3 CHIRALITY : 0.059 695 REMARK 3 PLANARITY : 0.006 759 REMARK 3 DIHEDRAL : 11.790 2601 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5MN5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-DEC-16. REMARK 100 THE DEPOSITION ID IS D_1200002741. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-FEB-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9792 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12051 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 4.400 REMARK 200 R MERGE (I) : 0.10900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.30 REMARK 200 R MERGE FOR SHELL (I) : 0.55400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3WGL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.94 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10 MG/ML; LICL 1.136 M, PEG 6,000 31.4 REMARK 280 %, 0.1 M MES PH 6, PH 6.0, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.89050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 93.83200 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.92500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 93.83200 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.89050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.92500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 12 REMARK 465 GLU A 63 REMARK 465 LYS A 64 REMARK 465 LEU A 65 REMARK 465 TRP A 66 REMARK 465 ARG A 67 REMARK 465 GLY A 68 REMARK 465 LEU A 69 REMARK 465 GLY A 70 REMARK 465 ALA A 71 REMARK 465 GLY A 72 REMARK 465 ALA A 73 REMARK 465 ASP A 316 REMARK 465 ALA B 12 REMARK 465 GLU B 63 REMARK 465 LYS B 64 REMARK 465 LEU B 65 REMARK 465 TRP B 66 REMARK 465 ARG B 67 REMARK 465 GLY B 68 REMARK 465 LEU B 69 REMARK 465 GLY B 70 REMARK 465 ALA B 71 REMARK 465 GLY B 72 REMARK 465 ALA B 73 REMARK 465 VAL B 203 REMARK 465 SER B 204 REMARK 465 GLY B 205 REMARK 465 GLU B 206 REMARK 465 VAL B 207 REMARK 465 ASN B 208 REMARK 465 ASP B 316 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASN B 299 OE1 GLU B 301 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU B 251 CB GLU B 251 CG 0.143 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 35 75.19 -153.24 REMARK 500 ASN A 220 13.56 51.27 REMARK 500 ASN A 235 44.64 -108.59 REMARK 500 GLN A 303 -78.42 -97.68 REMARK 500 ASN B 37 -18.85 -177.50 REMARK 500 ASN B 220 14.60 49.38 REMARK 500 ASN B 235 45.70 -109.88 REMARK 500 GLU B 288 -47.73 -21.13 REMARK 500 GLN B 303 -78.27 -92.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GTP A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GTP B 401 DBREF 5MN5 A 12 316 UNP P0A031 FTSZ_STAAU 12 316 DBREF 5MN5 B 12 316 UNP P0A031 FTSZ_STAAU 12 316 SEQADV 5MN5 TRP A 66 UNP P0A031 THR 66 ENGINEERED MUTATION SEQADV 5MN5 TRP B 66 UNP P0A031 THR 66 ENGINEERED MUTATION SEQRES 1 A 305 ALA THR LEU LYS VAL ILE GLY VAL GLY GLY GLY GLY ASN SEQRES 2 A 305 ASN ALA VAL ASN ARG MET ILE ASP HIS GLY MET ASN ASN SEQRES 3 A 305 VAL GLU PHE ILE ALA ILE ASN THR ASP GLY GLN ALA LEU SEQRES 4 A 305 ASN LEU SER LYS ALA GLU SER LYS ILE GLN ILE GLY GLU SEQRES 5 A 305 LYS LEU TRP ARG GLY LEU GLY ALA GLY ALA ASN PRO GLU SEQRES 6 A 305 ILE GLY LYS LYS ALA ALA GLU GLU SER ARG GLU GLN ILE SEQRES 7 A 305 GLU ASP ALA ILE GLN GLY ALA ASP MET VAL PHE VAL THR SEQRES 8 A 305 SER GLY MET GLY GLY GLY THR GLY THR GLY ALA ALA PRO SEQRES 9 A 305 VAL VAL ALA LYS ILE ALA LYS GLU MET GLY ALA LEU THR SEQRES 10 A 305 VAL GLY VAL VAL THR ARG PRO PHE SER PHE GLU GLY ARG SEQRES 11 A 305 LYS ARG GLN THR GLN ALA ALA ALA GLY VAL GLU ALA MET SEQRES 12 A 305 LYS ALA ALA VAL ASP THR LEU ILE VAL ILE PRO ASN ASP SEQRES 13 A 305 ARG LEU LEU ASP ILE VAL ASP LYS SER THR PRO MET MET SEQRES 14 A 305 GLU ALA PHE LYS GLU ALA ASP ASN VAL LEU ARG GLN GLY SEQRES 15 A 305 VAL GLN GLY ILE SER ASP LEU ILE ALA VAL SER GLY GLU SEQRES 16 A 305 VAL ASN LEU ASP PHE ALA ASP VAL LYS THR ILE MET SER SEQRES 17 A 305 ASN GLN GLY SER ALA LEU MET GLY ILE GLY VAL SER SER SEQRES 18 A 305 GLY GLU ASN ARG ALA VAL GLU ALA ALA LYS LYS ALA ILE SEQRES 19 A 305 SER SER PRO LEU LEU GLU THR SER ILE VAL GLY ALA GLN SEQRES 20 A 305 GLY VAL LEU MET ASN ILE THR GLY GLY GLU SER LEU SER SEQRES 21 A 305 LEU PHE GLU ALA GLN GLU ALA ALA ASP ILE VAL GLN ASP SEQRES 22 A 305 ALA ALA ASP GLU ASP VAL ASN MET ILE PHE GLY THR VAL SEQRES 23 A 305 ILE ASN PRO GLU LEU GLN ASP GLU ILE VAL VAL THR VAL SEQRES 24 A 305 ILE ALA THR GLY PHE ASP SEQRES 1 B 305 ALA THR LEU LYS VAL ILE GLY VAL GLY GLY GLY GLY ASN SEQRES 2 B 305 ASN ALA VAL ASN ARG MET ILE ASP HIS GLY MET ASN ASN SEQRES 3 B 305 VAL GLU PHE ILE ALA ILE ASN THR ASP GLY GLN ALA LEU SEQRES 4 B 305 ASN LEU SER LYS ALA GLU SER LYS ILE GLN ILE GLY GLU SEQRES 5 B 305 LYS LEU TRP ARG GLY LEU GLY ALA GLY ALA ASN PRO GLU SEQRES 6 B 305 ILE GLY LYS LYS ALA ALA GLU GLU SER ARG GLU GLN ILE SEQRES 7 B 305 GLU ASP ALA ILE GLN GLY ALA ASP MET VAL PHE VAL THR SEQRES 8 B 305 SER GLY MET GLY GLY GLY THR GLY THR GLY ALA ALA PRO SEQRES 9 B 305 VAL VAL ALA LYS ILE ALA LYS GLU MET GLY ALA LEU THR SEQRES 10 B 305 VAL GLY VAL VAL THR ARG PRO PHE SER PHE GLU GLY ARG SEQRES 11 B 305 LYS ARG GLN THR GLN ALA ALA ALA GLY VAL GLU ALA MET SEQRES 12 B 305 LYS ALA ALA VAL ASP THR LEU ILE VAL ILE PRO ASN ASP SEQRES 13 B 305 ARG LEU LEU ASP ILE VAL ASP LYS SER THR PRO MET MET SEQRES 14 B 305 GLU ALA PHE LYS GLU ALA ASP ASN VAL LEU ARG GLN GLY SEQRES 15 B 305 VAL GLN GLY ILE SER ASP LEU ILE ALA VAL SER GLY GLU SEQRES 16 B 305 VAL ASN LEU ASP PHE ALA ASP VAL LYS THR ILE MET SER SEQRES 17 B 305 ASN GLN GLY SER ALA LEU MET GLY ILE GLY VAL SER SER SEQRES 18 B 305 GLY GLU ASN ARG ALA VAL GLU ALA ALA LYS LYS ALA ILE SEQRES 19 B 305 SER SER PRO LEU LEU GLU THR SER ILE VAL GLY ALA GLN SEQRES 20 B 305 GLY VAL LEU MET ASN ILE THR GLY GLY GLU SER LEU SER SEQRES 21 B 305 LEU PHE GLU ALA GLN GLU ALA ALA ASP ILE VAL GLN ASP SEQRES 22 B 305 ALA ALA ASP GLU ASP VAL ASN MET ILE PHE GLY THR VAL SEQRES 23 B 305 ILE ASN PRO GLU LEU GLN ASP GLU ILE VAL VAL THR VAL SEQRES 24 B 305 ILE ALA THR GLY PHE ASP HET GTP A 401 32 HET GTP B 401 32 HETNAM GTP GUANOSINE-5'-TRIPHOSPHATE FORMUL 3 GTP 2(C10 H16 N5 O14 P3) HELIX 1 AA1 GLY A 20 HIS A 33 1 14 HELIX 2 AA2 ASP A 46 LEU A 52 1 7 HELIX 3 AA3 PRO A 75 SER A 85 1 11 HELIX 4 AA4 SER A 85 GLN A 94 1 10 HELIX 5 AA5 GLY A 107 MET A 124 1 18 HELIX 6 AA6 PHE A 136 GLU A 139 5 4 HELIX 7 AA7 GLY A 140 VAL A 158 1 19 HELIX 8 AA8 ASP A 167 ILE A 172 5 6 HELIX 9 AA9 PRO A 178 MET A 180 5 3 HELIX 10 AB1 GLU A 181 ASP A 199 1 19 HELIX 11 AB2 ASP A 210 SER A 219 1 10 HELIX 12 AB3 ASN A 235 SER A 246 1 12 HELIX 13 AB4 SER A 253 ALA A 257 5 5 HELIX 14 AB5 SER A 271 ALA A 286 1 16 HELIX 15 AB6 GLY B 20 HIS B 33 1 14 HELIX 16 AB7 ASP B 46 LEU B 52 1 7 HELIX 17 AB8 PRO B 75 SER B 85 1 11 HELIX 18 AB9 SER B 85 GLN B 94 1 10 HELIX 19 AC1 GLY B 107 MET B 124 1 18 HELIX 20 AC2 PHE B 136 GLU B 139 5 4 HELIX 21 AC3 GLY B 140 VAL B 158 1 19 HELIX 22 AC4 ASP B 167 LEU B 170 5 4 HELIX 23 AC5 PRO B 178 MET B 180 5 3 HELIX 24 AC6 GLU B 181 ASP B 199 1 19 HELIX 25 AC7 ASP B 210 SER B 219 1 10 HELIX 26 AC8 ASN B 235 SER B 246 1 12 HELIX 27 AC9 SER B 253 ALA B 257 5 5 HELIX 28 AD1 SER B 271 ALA B 286 1 16 SHEET 1 AA110 SER A 57 GLN A 60 0 SHEET 2 AA110 GLU A 39 ASN A 44 1 N ALA A 42 O SER A 57 SHEET 3 AA110 LEU A 14 VAL A 19 1 N GLY A 18 O ILE A 43 SHEET 4 AA110 MET A 98 GLY A 104 1 O PHE A 100 N ILE A 17 SHEET 5 AA110 LEU A 127 ARG A 134 1 O VAL A 129 N VAL A 99 SHEET 6 AA110 THR A 160 PRO A 165 1 O ILE A 162 N GLY A 130 SHEET 7 AA110 GLY A 222 SER A 231 1 O GLY A 222 N LEU A 161 SHEET 8 AA110 ILE A 306 THR A 313 -1 O ALA A 312 N LEU A 225 SHEET 9 AA110 GLY A 259 GLY A 266 -1 N LEU A 261 O ILE A 311 SHEET 10 AA110 ASN A 291 ILE A 298 1 O ASN A 291 N VAL A 260 SHEET 1 AA210 SER B 57 GLN B 60 0 SHEET 2 AA210 VAL B 38 ASN B 44 1 N ALA B 42 O ILE B 59 SHEET 3 AA210 LEU B 14 VAL B 19 1 N GLY B 18 O ILE B 43 SHEET 4 AA210 MET B 98 GLY B 104 1 O PHE B 100 N ILE B 17 SHEET 5 AA210 LEU B 127 ARG B 134 1 O VAL B 129 N VAL B 99 SHEET 6 AA210 THR B 160 PRO B 165 1 O ILE B 162 N GLY B 130 SHEET 7 AA210 GLY B 222 SER B 231 1 O ALA B 224 N LEU B 161 SHEET 8 AA210 ILE B 306 THR B 313 -1 O ILE B 306 N SER B 231 SHEET 9 AA210 GLY B 259 GLY B 266 -1 N LEU B 261 O ILE B 311 SHEET 10 AA210 ASN B 291 ILE B 298 1 O ASN B 291 N VAL B 260 SITE 1 AC1 17 GLY A 20 GLY A 21 GLY A 22 ASN A 25 SITE 2 AC1 17 GLY A 104 MET A 105 GLY A 107 GLY A 108 SITE 3 AC1 17 THR A 109 GLY A 110 PRO A 135 GLU A 139 SITE 4 AC1 17 ARG A 143 PHE A 183 ALA A 186 ASP A 187 SITE 5 AC1 17 LEU A 190 SITE 1 AC2 17 GLY B 20 GLY B 21 GLY B 22 ASN B 25 SITE 2 AC2 17 GLY B 104 MET B 105 GLY B 107 GLY B 108 SITE 3 AC2 17 THR B 109 GLY B 110 PRO B 135 GLU B 139 SITE 4 AC2 17 ARG B 143 ASN B 166 PHE B 183 ALA B 186 SITE 5 AC2 17 ASP B 187 CRYST1 43.781 59.850 187.664 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022841 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016708 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005329 0.00000